Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) EBITDA (2016 - 2026)

Cannabis Suisse has reported EBITDA over the past 11 years, most recently at -$68333.0 for Q1 2026.

  • Quarterly EBITDA fell 3.96% to -$68333.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$278742.0 through Feb 2026, up 10.79% year-over-year, with the annual reading at -$283769.0 for FY2025, 12.3% down from the prior year.
  • EBITDA was -$68333.0 for Q1 2026 at Cannabis Suisse, up from -$73919.0 in the prior quarter.
  • Over five years, EBITDA peaked at -$22473.0 in Q2 2022 and troughed at -$154991.0 in Q1 2023.
  • The 5-year median for EBITDA is -$65727.0 (2025), against an average of -$68451.8.
  • Year-over-year, EBITDA skyrocketed 96.67% in 2022 and then tumbled 281.93% in 2023.
  • A 5-year view of EBITDA shows it stood at -$28314.0 in 2022, then crashed by 75.32% to -$49641.0 in 2023, then plummeted by 83.82% to -$91248.0 in 2024, then grew by 18.99% to -$73919.0 in 2025, then increased by 7.56% to -$68333.0 in 2026.
  • Per Business Quant, the three most recent readings for CSUI's EBITDA are -$68333.0 (Q1 2026), -$73919.0 (Q4 2025), and -$83474.0 (Q3 2025).